1-2 of 2
Jyotirmoy Dey
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Updated Safety and Efficacy of REGN5458, a BCMAxCD3 Bispecific Antibody, Treatment for Relapsed/Refractory Multiple Myeloma: A Phase 1/2 First-in-Human Study

Naresh Bumma, Joshua Richter, Jason Brayer, Jeffrey A. Zonder, Madhav Dhodapkar, Mansi R. Shah, James E. Hoffman, Raya Mawad, Joseph J. Maly, Suzanne Lentzsch, Attaya Suvannasankha, Pourab Roy, Jyotirmoy Dey, Dhruti Chokshi, Anita Boyapati, Jenn Visich, Yariv Houvras, Karen Rodriguez Lorenc, Glenn S. Kroog, Sundar Jagannath
Journal: Blood
Blood (2022) 140 (Supplement 1): 10140–10141.
https://doi.org/10.1182/blood-2022-159969
Published: 2022
Journal Articles

Clinical Activity of Lucatumumab (HCD122) In Patients (pts) with Relapsed/Refractory Hodgkin or Non-Hodgkin Lymphoma Treated In a Phase Ia/II Clinical Trial (NCT00670592)

Arnold S. Freedman, MD, John Kuruvilla, MD, Sarit E. Assouline, MD, Andreas Engert, MD, DaeSeog Heo, MD, Philippe Solal-Celigny, MD, Paolo Corradini, MD, Gregor Verhoef, MD, PhD, Michelle A. Fanale, MD, Jennifer Bendiske, PhD, Brett Ewald, PhD, Jyotirmoy Dey, PhD, Johan Baeck, MD, Anas Younes, MD
Journal: Blood
Blood (2010) 116 (21): 284.
https://doi.org/10.1182/blood.V116.21.284.284
Published: 2010